Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wingfield Chemical Industry is a specialized pharmaceutical manufacturer based in Taiwan that focuses on the production of Active Pharmaceutical Ingredients (APIs) and fine chemical intermediates. Founded in 1976, the company has established a reputation for high-quality small molecule synthesis, operating facilities that adhere to international Good Manufacturing Practice (GMP) standards. Their core product offerings include generic APIs such as Methocarbamol and Guaifenesin, which are supplied to pharmaceutical formulators worldwide. In addition to its catalog of products, Wingfield offers contract manufacturing and custom synthesis services to support drug development and commercialization. The company plays a vital role in the global supply chain for essential generic medications and has been inspected by major regulatory bodies including the US FDA.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wingfield Chemical Industry.